The antifibrotic effect of Longidaze in the pulmonary fibrosis model was manifested by a decrease in the area of connective tissue in the lungs of mice and a decrease in the levels of profibrotic mediators (TGF-β1, type 1 collagen, hydroxyproline) in the lung tissue. Here, TGFB1 is linked to pulmonary fibrosis.